Goodbody Health Limited
GDBYF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 7/31/2018 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 755.5% | 37.6% | 220.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 52.4% | 56.4% | 52% | 0% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -0.1% | -206.6% | -227.3% | -38.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13.6% | -233.7% | -262.1% | -77.1% |
| EPS Diluted | -0.067 | -0.29 | -0.48 | -0.17 |
| % Growth | 76.9% | 39.6% | -182.4% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |